For most seniors, yes, the shingles vaccine (Shingrix) is free. If you have Medicare Part D or a private health insurance plan, you should pay nothing out of pocket for either dose. This wasn’t always the case. A law that took effect in January 2023 eliminated the copays and deductibles that previously made the vaccine cost seniors anywhere from $50 to the full retail price of about $200 per dose.
Why Shingrix Is Now Free Under Medicare
The Inflation Reduction Act, signed in 2022, eliminated cost sharing and deductibles for all adult vaccines recommended by the federal Advisory Committee on Immunization Practices (ACIP) and covered under Medicare Part D. That change kicked in on January 1, 2023. Before that date, many Medicare enrollees faced copays that varied by plan, sometimes $50 or more per dose. Since Shingrix requires two doses, those costs added up quickly and discouraged many seniors from getting vaccinated.
Now, your Part D plan cannot charge you a copayment or apply a deductible for Shingrix. This applies even if you get the vaccine from an out-of-network provider, such as a pharmacy that isn’t in your plan’s preferred network. Medicare.gov puts it plainly: “You usually pay nothing for the shingles shot if you have Part D.”
What About Medicare Part B?
Shingrix is not covered under Medicare Part B. Part B handles a limited set of vaccines, primarily the flu shot and COVID-19 vaccines, but shingles falls under Part D. If you have Original Medicare without a Part D prescription drug plan, the vaccine will not be covered at all, and you’d be responsible for the full retail cost of roughly $400 for both doses. Medicare Advantage plans that include drug coverage (Part C with Part D) follow the same zero-cost rules as standalone Part D plans.
Coverage Through Private Insurance
If you’re between 50 and 64 and still on an employer or marketplace health plan, the Affordable Care Act requires most private insurers to cover ACIP-recommended vaccines at no cost to you. Shingrix falls into that category for adults 50 and older. That means no copay, no coinsurance, and no deductible. Grandfathered plans (those that existed before the ACA and haven’t made certain changes) are the main exception. If your plan is grandfathered, check with your insurer directly.
Medicaid Coverage Varies by State
Medicaid coverage for Shingrix is less straightforward. The CDC notes that Medicaid “may or may not cover the vaccine” depending on where you live. Some state Medicaid programs cover it fully, others partially, and some not at all. If Medicaid is your primary coverage, contact your state’s Medicaid office or your managed care plan before scheduling the shot so you know what to expect.
If You Have No Insurance
Without any insurance, Shingrix costs about $200 per dose, or $400 for the full two-dose series. That’s a significant expense, but there are options. GlaxoSmithKline, the manufacturer, offers a patient assistance program for eligible uninsured or underinsured adults. Some community health centers and local health departments also provide vaccines on a sliding fee scale. If cost is a barrier, calling your local pharmacy or health department is a good starting point.
Watch for Billing Issues
Even though the vaccine should be free for most seniors, billing errors do happen. The most common issue is a pharmacy or doctor’s office that doesn’t bill your Part D plan correctly, leaving you with an unexpected charge. You can avoid this by asking upfront whether the provider can bill your Part D plan directly. Pharmacies like CVS, Walgreens, and most grocery store pharmacies are generally set up to do this, but it’s worth confirming before you roll up your sleeve.
If you do receive a bill, contact your Part D plan. Under current rules, you should not owe anything for a recommended vaccine, and the plan is required to reimburse you or correct the billing.
Who Should Get Shingrix
Shingrix is recommended for all adults 50 and older, regardless of whether you remember having chickenpox or have already had shingles. The vaccine is given as two doses, spaced two to six months apart. Both doses are necessary for full protection.
Adults younger than 50 can also qualify if they have a weakened immune system due to a medical condition or treatment such as chemotherapy, organ transplant medications, or autoimmune disease therapy. In 2021, the FDA expanded approval to include immunocompromised adults as young as 18, and ACIP now recommends Shingrix for immunodeficient or immunosuppressed adults 19 and older. If you fall into this group, your insurance should still cover the vaccine at no cost, since it carries an ACIP recommendation.